AlloVir, Inc. (ALVR)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 09:30AM EDT. Market open.
| Previous close | 0.8100 |
| Open | 0.8000 |
| Bid | 0.7580 x 200 |
| Ask | 0.8420 x 200 |
| Day's range | 0.7900 - 0.8000 |
| 52-week range | 0.6230 - 6.1200 |
| Volume | |
| Avg. volume | 594,178 |
| Market cap | 90.781M |
| Beta (5Y monthly) | 0.85 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.8300 |
| Earnings date | 02 May 2024 - 06 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 1.00 |
Simply Wall St.Is AlloVir (NASDAQ:ALVR) In A Good Position To Deliver On Growth Plans?
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com...
ZacksAre Medical Stocks Lagging AlloVir (ALVR) This Year?
Here is how AlloVir, Inc. (ALVR) and Arcutis Biotherapeutics, Inc. (ARQT) have performed compared to their sector so far this year.
ZacksDown -72.39% in 4 Weeks, Here's Why You Should You Buy the Dip in AlloVir, Inc. (ALVR)
AlloVir, Inc. (ALVR) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
© 2024 Yahoo. All rights reserved.